歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

佛诞节休市 05-02 16:08:25

6.550

+0.200

+3.15%

最高6.610	最低6.300	成交量140.30万
今开6.350	昨收6.350	日振幅4.88%
总市值63.14亿	流通市值63.14亿	总股本9.64亿
成交额908.93万	换手率0.15%	流通股本9.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":6.55,"timestamp":1746173305029,"preClose":6.35,"halted":0,"volume":1403000,"delay":0,"floatShares":964000000,"shares":964000000,"eps":-0.32345497908254606,"marketStatus":"佛诞节休市","change":0.2,"latestTime":"05-02 16:08:25","open":6.35,"high":6.61,"low":6.3,"amount":9089305,"amplitude":0.048819,"askPrice":6.55,"askSize":14000,"bidPrice":6.49,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.32345497908254606,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":7,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":6.35,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.3863482004642826,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2531038672","title":"歌礼制药-B(01672)因购股权获行使合计发行4.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531038672","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531038672?lang=zh_cn&edition=full","pubTime":"2025-04-30 19:06","pubTimestamp":1746011194,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权，本公司于2025年4月30日发行1.8万股普通股。由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权，本公司于2025年4月30日发行2.2万股普通股。由于合资格参与者根据本公司于2019年6月6日采纳的购股权计划行使购股权，本公司于2025年4月30日发行7000股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","01477","BK1574","BK1191","01672"],"gpt_icon":0},{"id":"2531503315","title":"歌礼制药-B04月30日主力净流出28.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531503315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531503315?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000922,"startTime":"0","endTime":"0","summary":"04月30日, 歌礼制药-B股价跌4.94%，报收6.35元，成交金额1092.6万元，换手率0.18%，振幅8.08%，量比0.32。歌礼制药-B今日主力资金净流出28.5万元，上一交易日主力净流入202.3万元。该股近5个交易日下跌1.87%，主力资金累计净流入15.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1629.1万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170430a6ce989f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170430a6ce989f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01672","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"2531170997","title":"【港股收评：恒生指数涨0.51%，恒生科技指数涨1.35%】港股收盘，恒生指数涨0.51%，恒生科技指数涨1.35%。港股科技ETF（159751）收盘上涨1.44%，恒生港股通ETF（159318）收盘上涨0.58%。美图公司涨超10%，周大福涨超8%。老铺黄金跌超5%，歌礼制药-B跌超4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531170997","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531170997?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:09","pubTimestamp":1746000575,"startTime":"0","endTime":"0","summary":"港股收盘，恒生指数涨0.51%，恒生科技指数涨1.35%。港股科技ETF（159751）收盘上涨1.44%，恒生港股通ETF（159318）收盘上涨0.58%。美图公司涨超10%，周大福涨超8%。老铺黄金跌超5%，歌礼制药-B跌超4%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30160950042174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1095","513020","BK1544","BK1612","02833","159318","IE00BYQNZ168.SGD","BK1515","BK4614","MCHmain","513990","BK1224","LU2125910500.SGD","HSI","BK1545","BK1618","01672","BK1602","BK1613","LU2045819591.USD","BK1227","159751","01477","HHImain","HSTECH","BK1609","IE00BYTNYN87.SGD","HSCEI","BK1502","BK1574","01357","BK1191","BK1601","SG9999011746.SGD","YANG","IE00B12V2V27.USD","01929","513600"],"gpt_icon":0},{"id":"2531786386","title":"歌礼制药-B(01672)4月29日根据获采纳购股权计划发行合共18.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786386","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531786386?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:58","pubTimestamp":1745924305,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年4月29日根据获采纳购股权计划发行合共18.75万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","01672","BK1161","01477","BK1574"],"gpt_icon":0},{"id":"2531228017","title":"歌礼制药-B盘中异动 下午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531228017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531228017?lang=zh_cn&edition=full","pubTime":"2025-04-29 13:46","pubTimestamp":1745905560,"startTime":"0","endTime":"0","summary":"2025年04月29日下午盘13时46分，歌礼制药-B股票出现波动，股价大幅拉升5.02%。截至发稿，该股报6.490港元/股，成交量126.498万股，换手率0.13%，振幅6.31%。资金方面，该股资金流入460.947万港元，流出257.256万港元。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134600a6ccb8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429134600a6ccb8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1574","BK1161","01672","BK1515"],"gpt_icon":0},{"id":"2531230898","title":"歌礼制药-B根据购股权计划发行17.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531230898","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531230898?lang=zh_cn&edition=full","pubTime":"2025-04-29 00:17","pubTimestamp":1745857020,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)发布公告，由于合资格参与者根据公司于2019年6月6日采...歌礼制药-B(01672)发布公告，由于合资格参与者根据公司于2019年6月6日采纳的购股权计划行使购股权，公司于2025年4月28日发行17.2万股普通股。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042900201294e61f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042900201294e61f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01672","BK1161","01477","BK1574"],"gpt_icon":0},{"id":"2530285626","title":"歌礼制药-B(01672)根据购股权计划发行17.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530285626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530285626?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:33","pubTimestamp":1745847187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，由于合资格参与者根据公司于2019年6月6日采纳的购股权计划行使购股权，公司于2025年4月28日发行17.2万股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01672","BK1191","01477","BK1161","BK1574"],"gpt_icon":0},{"id":"2530441476","title":"加入GLP-1混战，“中国本土丙肝药一哥”换赛道，歌礼制药欲靠减肥药翻身","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441476","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530441476?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:01","pubTimestamp":1745823691,"startTime":"0","endTime":"0","summary":"昔日被业界称为“中国本土丙肝一哥”的歌礼制药（01672.HK），如今官网上已经鲜少有丙肝产品的身影。GLP-1类药物取而代之，在官网管线中排位靠前，官方微信公众号亦频繁披露GLP-1减重产品相关数据。这似乎预示着，这家以丙肝药物起家的药企正意欲借助GLP-1药物打一场翻身战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504283391113086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1161","GLP","BK4590","BK4144","01477","BK1574","BK1191","01672"],"gpt_icon":0},{"id":"2530183307","title":"歌礼制药-B(01672)4月25日根据股份计划合计发行12.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530183307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530183307?lang=zh_cn&edition=full","pubTime":"2025-04-25 18:49","pubTimestamp":1745578164,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年4月25日，该公司就根据股份计划授予参与人(发行人的董事除外)的股份奖励或期权而合计发行12.8万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","01672","BK1191","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2530508903","title":"歌礼制药-B04月25日遭主力抛售168万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530508903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530508903?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:16","pubTimestamp":1745568965,"startTime":"0","endTime":"0","summary":"04月25日, 歌礼制药-B股价跌6.69%，报收6.28元，成交金额2750万元，换手率0.44%，振幅12.18%，量比0.47。歌礼制药-B今日主力资金净流出168万元，连续3日净流出，上一交易日主力净流出5万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为5.18%。该股近5个交易日上涨22.39%，主力资金累计净流出1385万元；近20日主力资金累计净流出1814万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170341a6c7cdf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170341a6c7cdf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01672","01477","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2530941409","title":"歌礼制药-B盘中异动 早盘急速下跌5.35%报6.370港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530941409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530941409?lang=zh_cn&edition=full","pubTime":"2025-04-25 11:09","pubTimestamp":1745550551,"startTime":"0","endTime":"0","summary":"2025年04月25日早盘11时09分，歌礼制药-B股票出现波动，股价大幅下跌5.35%。截至发稿，该股报6.370港元/股，成交量200.3万股，换手率0.21%，振幅10.25%。歌礼制药-B股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，腾盛博药-B、维升药业-B、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、来凯医药-B、歌礼制药-B，振幅分别为15.62%、11.68%、9.51%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425110911a466388e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425110911a466388e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1574","BK1161","BK1515","01672"],"gpt_icon":0},{"id":"2530131749","title":"歌礼制药-B因购股权获行使发行25.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131749","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530131749?lang=zh_cn&edition=full","pubTime":"2025-04-25 07:57","pubTimestamp":1745539020,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　歌礼制药-B（01672）发布公告，于2025年4月24日，因购股权获行使发行合计25.4万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-25/doc-ineuiriy1494058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01672","BK1574","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"2529933777","title":"歌礼制药-B(01672)因购股权获行使发行25.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529933777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529933777?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:31","pubTimestamp":1745501471,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年4月24日，因购股权获行使发行合计25.4万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1574","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"2529610266","title":"歌礼制药-B盘中涨近10% 治疗肥胖症药物研究获积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529610266","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529610266?lang=zh_cn&edition=full","pubTime":"2025-04-24 12:00","pubTimestamp":1745467200,"startTime":"0","endTime":"0","summary":"　　歌礼制药-B早盘一度涨近10%，截至发稿，股价上涨4.67%，报6.73港元，成交额3440.00万港元。　　歌礼制药公布，其自主研发的小分子口服GLP-1受体激动剂ASC30于美国进行的Ib期多剂量递增研究取得积极顶线结果，并已向美国食品药品监督管理局提交IIa期研究方案，预计将于2025年第三季度初开展。　　据悉，由歌礼自主研发的ASC30是首款也是唯一一款既可每日一次口服也可每月一次皮下注射的用于治疗肥胖症的在研小分子GLP-1受体激动剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-24/doc-ineufssz3653975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","01477","BK1574","BK1161","01672","BK1515"],"gpt_icon":0},{"id":"2529261294","title":"港股异动 | 歌礼制药-B(01672)早盘涨近10% 治疗肥胖症药物研究获积极顶线结果 已向FDA提交IIa期研究方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2529261294","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529261294?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:31","pubTimestamp":1745465512,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B早盘涨近10%，截至发稿，涨5.13%，报6.76港元，成交额3391.17万港元。消息面上，歌礼制药公布，其自主研发的小分子口服GLP-1受体激动剂ASC30于美国进行的Ib期多剂量递增研究取得积极顶线结果，并已向美国食品药品监督管理局提交IIa期研究方案，预计将于2025年第三季度初开展。ASC30是一种新化学实体，拥有美国和全球化合物专利保护，专利保护期至2044年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","01477","BK1515","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"2529617383","title":"歌礼制药早盘涨近10%治疗肥胖症药物研究获积极顶线结果已向FDA提交IIa期研究方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2529617383","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529617383?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:31","pubTimestamp":1745465460,"startTime":"0","endTime":"0","summary":"歌礼制药-B股票早盘涨近10%，其自研的肥胖症药物ASC30在美国的Ib期研究获积极结果，并已向FDA提交IIa期研究方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042411412394e070e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042411412394e070e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1161","BK1191","01477","BK1515"],"gpt_icon":0},{"id":"2529061374","title":"歌礼制药-B盘中异动 早盘股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529061374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529061374?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:43","pubTimestamp":1745458981,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘09时43分，歌礼制药-B股票出现异动，股价大幅上涨5.60%。截至发稿，该股报6.790港元/股，成交量71.7万股，换手率0.07%，振幅5.75%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，宜明昂科-B、荣昌生物、亚盛医药-B涨幅较大，振幅较大的相关个股有宜明昂科-B、乐普生物-B、来凯医药-B，振幅分别为7.34%、7.16%、6.58%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504240943019742d7dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504240943019742d7dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1574","BK1161","BK1515","01672"],"gpt_icon":0},{"id":"2529597539","title":"【港股医药股延续涨势 宜明昂科涨超11%】截至发稿，宜明昂科-B(01541.HK)涨11.17%、欧康维视生物-B(01477.HK)涨9.96%、 歌礼制药-B(01672.HK)涨9.27%、药明巨诺-B(02126.HK)涨8.67%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529597539","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529597539?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:57","pubTimestamp":1745373425,"startTime":"0","endTime":"0","summary":"截至发稿，宜明昂科-B(01541.HK)涨11.17%、欧康维视生物-B(01477.HK)涨9.96%、 歌礼制药-B(01672.HK)涨9.27%、药明巨诺-B(02126.HK)涨8.67%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/23095749776966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01672","01541","BK1161","02126","159718","BK1191","BK1583","BK1574","BK1515","01477"],"gpt_icon":0},{"id":"2529597382","title":"港股异动 | 歌礼制药(01672)再涨超10% ASC30美国Ib期多剂量递增研究取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529597382","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529597382?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:54","pubTimestamp":1745373258,"startTime":"0","endTime":"0","summary":"消息面上，歌礼制药发布公告，公司董事会宣布其ASC30每日一次口服片在美国肥胖症受试者中开展的随机、双盲、安慰剂对照Ib期多剂量递增 研究取得积极顶线结果。4月17日，礼来宣布口服药Orforglipron的III期ACHIEVE-1研究取得积极顶线结果，在糖化血红蛋白管理、体重控制和安全性方面均与注射剂型相仿，即将申报上市。据悉，目前歌礼制药旗下ASC30是唯一一款即可以口服，又可以超长效皮下注射的小分子GLP-1药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","01672","BK1161","01477","BK1574"],"gpt_icon":0},{"id":"2529929445","title":"歌礼制药-B盘中异动 早盘股价大涨5.69%报6.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529929445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529929445?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:30","pubTimestamp":1745371809,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘09时30分，歌礼制药-B股票出现异动，股价快速拉升5.69%。截至发稿，该股报6.500港元/股，成交量11.3万股，换手率0.01%，振幅2.28%。资金方面，该股资金流入44.321万港元，流出1.282万港元。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中，整体涨幅为3.01%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042309300997415fd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042309300997415fd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","BK1515","01672","01477","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":0.043},{"period":"1month","weight":-0.1449},{"period":"3month","weight":0.6173},{"period":"6month","weight":3.6454},{"period":"1year","weight":3.6786},{"period":"ytd","weight":1.1761}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.1127},{"period":"6month","weight":0.0974},{"period":"1year","weight":0.236},{"period":"ytd","weight":0.1219}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.017585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.138187},{"month":12,"riseRate":0.571429,"avgChangeRate":0.13144}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}